Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.7M Buy
78,199
+2,782
+4% +$599K 0.82% 33
2026
Q1
$16.4M Buy
75,417
+796
+1% +$177K 0.77% 37
2025
Q4
$17.1M Sell
74,621
-375
-0.5% -$85.4K 0.76% 39
2025
Q3
$17.4M Sell
74,996
-3,097
-4% -$631K 0.8% 36
2025
Q2
$14.5M Buy
78,093
+451
+0.6% +$83.8K 0.63% 48
2025
Q1
$16.3M Buy
77,642
+4,897
+7% +$952K 0.74% 41
2024
Q4
$12.9M Sell
72,745
-1,608
-2% -$296K 0.85% 36
2024
Q3
$14.7M Sell
74,353
-1,508
-2% -$281K 1.01% 30
2024
Q2
$13M Buy
75,861
+6,186
+9% +$1.02M 0.95% 30
2024
Q1
$12.7M Buy
69,675
+1,601
+2% +$276K 0.99% 31
2023
Q4
$10.5M Buy
68,074
+661
+1% +$96.4K 0.9% 37
2023
Q3
$10M Sell
67,413
-299
-0.4% -$43.9K 0.95% 33
2023
Q2
$9.12M Buy
67,712
+582
+0.9% +$85.3K 0.82% 40
2023
Q1
$10.7M Sell
67,130
-2,636
-4% -$403K 0.99% 30
2022
Q4
$11.3M Buy
69,766
+1,949
+3% +$299K 1.04% 29
2022
Q3
$9.1M Buy
67,817
+3,151
+5% +$452K 0.91% 35
2022
Q2
$9.9M Buy
64,666
+5,359
+9% +$819K 0.93% 34
2022
Q1
$9.61M Buy
59,307
+4,935
+9% +$717K 0.76% 41
2021
Q4
$7.36M Buy
54,372
+2,726
+5% +$322K 0.57% 53
2021
Q3
$5.57M Buy
51,646
+684
+1% +$78.2K 0.47% 61
2021
Q2
$5.74M Buy
50,962
+1,848
+4% +$208K 0.49% 57
2021
Q1
$5.25M Buy
49,114
+6,352
+15% +$679K 0.49% 56
2020
Q4
$4.83M Buy
42,762
+9,226
+28% +$887K 0.48% 60
2020
Q3
$2.94M Buy
33,536
+5,076
+18% +$478K 0.31% 81
2020
Q2
$2.79M Buy
28,460
+20,206
+245% +$1.78M 0.34% 71
2020
Q1
$629K Sell
8,254
-2,537
-24% -$216K 0.09% 145
2019
Q4
$955K Buy
10,791
+3,780
+54% +$314K 0.11% 141
2019
Q3
$531K Sell
7,011
-3,075
-30% -$211K 0.07% 165
2019
Q2
$734K Sell
10,086
-1,500
-13% -$118K 0.08% 147
2019
Q1
$934K Sell
11,586
-665
-5% -$54.4K 0.1% 141
2018
Q4
$1.13M Sell
12,251
-492
-4% -$43.3K 0.13% 122
2018
Q3
$1.2M Buy
12,743
+309
+2% +$29.3K 0.12% 128
2018
Q2
$1.15M Sell
12,434
-1,050
-8% -$103K 0.13% 138
2018
Q1
$1.28M Buy
13,484
+298
+2% +$32.7K 0.15% 126
2017
Q4
$1.27M Sell
13,186
-661
-5% -$62.3K 0.14% 133
2017
Q3
$1.23K Sell
13,847
-1,850
-12% -$141K 0.14% 121
2017
Q2
$1.14M Sell
15,697
-301
-2% -$20.2K 0.15% 126
2017
Q1
$1.04M Sell
15,998
-5,675
-26% -$357K 0.14% 134
2016
Q4
$1.36M Sell
21,673
-10,660
-33% -$651K 0.2% 114
2016
Q3
$2.04M Sell
32,333
-1,862
-5% -$121K 0.31% 92
2016
Q2
$2.12M Buy
34,195
+523
+2% +$31.9K 0.32% 88
2016
Q1
$1.92M Sell
33,672
-802
-2% -$44.7K 0.3% 93
2015
Q4
$2.04M Buy
34,474
+95
+0.3% +$5.47K 0.32% 94
2015
Q3
$1.87M Sell
34,379
-1,559
-4% -$101K 0.29% 104
2015
Q2
$2.42M Sell
35,938
-13
-0% -$849 0.34% 93
2015
Q1
$2.1M Buy
35,951
+882
+3% +$53.3K 0.3% 99
2014
Q4
$2.3M Sell
35,069
-5,013
-13% -$316K 0.36% 85
2014
Q3
$2.32M Sell
40,082
-4,304
-10% -$239K 0.35% 86
2014
Q2
$2.5M Sell
44,386
-165
-0.4% -$8.66K 0.41% 81
2014
Q1
$2.29M Buy
44,551
+2,152
+5% +$109K 0.37% 89
2013
Q4
$2.24M Buy
42,399
+188
+0.4% +$9.24K 0.37% 85
2013
Q3
$1.89M Buy
42,211
+6,385
+18% +$283K 0.35% 91
2013
Q2
$1.48M Buy
+35,826
New +$1.57M 0.31% 90

Other funds holding ABBV

SouthState Corp's ABBV Position: Q2 2026 in Review

SouthState Corp increased its AbbVie (ABBV) stake by 3.7% in Q2 2026, buying an estimated $599K and bringing the position to 78,199 shares worth $19.7M. The position accounts for 0.82% of the portfolio, ranked #33.

SouthState Corp first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 4,189 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • SouthState Corp held 78,199 shares of AbbVie worth $19.7M as of Q2 2026.
  • SouthState Corp bought 2,782 AbbVie shares in Q2 2026, an estimated $599K.
  • AbbVie made up 0.82% of SouthState Corp's portfolio in Q2 2026, its #33 holding.
  • SouthState Corp first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • 4,189 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on SouthState Corp's 13F filing for Q2 2026, filed 6 Aug 2026.